What is the angiodefender?

The AngioDefender system is not commercially available in the United States.

When healthcare providers can assess a patient’s risk of cardiovascular disease (CVD) years before symptoms exist, their patients are less likely to develop serious coronary problems later in life.

The problem is, most of these tests are invasive, expensive and time-consuming, requiring highly trained medical staff to facilitate them. Until now.

The AngioDefender™ from Everist Health detects early stage CVD and atherosclerosis with a non-invasive test that’s fast and cost-effective. By combining patent-protected sensor technology with a sophisticated software algorithm, the AngioDefender allows providers to detect CVD and heart disease outside of conventional risk factors, before a patient shows symptoms and without an invasive procedure in less than 20 minutes.

The system works by measuring endothelial function to detect coronary health issues, arterial diseases, pulmonary embolism and more. And when partnered with the Vascular Age Calculator, patients can calculate their vascular age to adjust behaviors and control risk factors.

The AngioDefender can also be used to monitor ongoing treatments for high blood pressure or cholesterol to prevent heart attacks, heart failure and stroke.



  1. American Heart Association. Heart Disease and Stroke Statistics, 2010

View our Clinical Validation or our CE Mark Certificate for more info (pdf)

View our PATIENT FLYER for more info (pdf)

How it Works

Learn about how the AngioDefender® system works and the major steps in the AngioDefender system test.

Comparison to other Methods

Understand the limitations of methods currently used to measure endothelial function and one’s risk of developing CVD.


Aliquam erat volutpat. Maecenas lobortis, augue eu tincidunt sagittis, dui erat varius dui, in consequat tellus an faucibus mauris. Ut imperdiet, leo non euismuris consequat tortor,te sed lorem.

Learn more about Partnering with Everist health